Evidence map›Paper›PMID 34237455›Full record

ReviewBiomedical journal2022

Modified natriuretic peptides and their potential roles in cancer treatment.

Mengjiao Xu, Xingzhu Liu, Ping Li, Yadong Yang, Wenyuan Zhang, Siyu Zhao, Ying Zeng, Xile Zhou, Ling-Hui Zeng, Geng Yang

Open access · goldAbstract readReview
In one paragraph

Review in Biomedical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. About gladiators and a sacred disease.Biomedical journal · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mengjiao XuDepartment of Pharmacology, School of Medicine, Zhejiang University City College, Hangzhou, China; School of Bioengineering, Hangzhou Medical College, Hangzhou, China.
Xingzhu LiuSchool of Bioengineering, Hangzhou Medical College, Hangzhou, China.
Ping LiSchool of Bioengineering, Hangzhou Medical College, Hangzhou, China.
Yadong YangSchool of Bioengineering, Hangzhou Medical College, Hangzhou, China.
Wenyuan ZhangSchool of Bioengineering, Hangzhou Medical College, Hangzhou, China.
Siyu ZhaoSchool of Bioengineering, Hangzhou Medical College, Hangzhou, China.
Ying ZengDepartment of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Xile ZhouDepartment of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Ling-Hui ZengDepartment of Pharmacology, School of Medicine, Zhejiang University City College, Hangzhou, China. Electronic address: zenglh@zucc.edu.cn.
Geng YangDepartment of Pharmacology, School of Medicine, Zhejiang University City College, Hangzhou, China. Electronic address: g_yang@zju.edu.cn.
Hangzhou Medical College · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The natriuretic peptide family (NPs) is a group of natural endocrine hormones, containing a 17-amino acid ring structure connected by disulfide bonds of two cysteines. In this review, the members of the natriuretic peptide family and their corresponding receptors as well as the anti-cancer effects are introduced. Four cardiac hormones of NPs (ANP, VD, KP and LANP) can effectively inhibit the growth of human small cell lung cancer, breast cancer and other tumors and significantly reduce tumor volume in vivo. The in vitro experiments also show that cardiac hormones, CNP and urodilatin can effectively inhibit the growth of most tumor cells. We then further summarized the anti-cancer mechanism of natriuretic peptides. Finally, we introduce several methods that modify natriuretic peptides, leading to enhance their stability and prolong the biological effects of these peptides, which might be helpful for the clinical application in the future. Peptide therapy is a very promising field for cancer treatments since they can induce the death of cancer cells without dramatically affecting normal cells. The synthesis of a useful and stable natriuretic peptide can enhance the effect of cancer treatments and significantly reduce drug resistance and toxicity.

Indexed as

Breast NeoplasmsReceptors, Atrial Natriuretic FactorFemaleHumansNatriuretic Peptide, BrainNatriuretic PeptidesNatriuretic Peptide, BrainNatriuretic PeptidesReceptors, Atrial Natriuretic FactorCancer treatmentNatriuretic peptide modificationNatriuretic peptides (NPs)Peptide therapy

Identifiers

PMID34237455
PMCPMC9133251
OpenAlexW3179195344

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.